ResearcherHarbin Medical UniversityActive in the last 2 years
Yan Luo
Matched on ORCID iD 0000-0002-3349-6036; OpenAlex author ID A5138808756. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2023: 2 papers · 2024: none · 2025: none · 2026: 2 papers
Papers 4
- Tumour-infiltrating adipocyte-derived 12,13-DiHOME subverts CD8+ T cell immunity in pancreatic ductal adenocarcinoma by promoting PPARγ-mediated ferritinophagy… Co-author DOI 10.1136/gutjnl-2025-337119↗
- Spatial Multiomics Analyses Reveal That Diabetes Promotes Pancreatic Cancer Progression by Stimulating Cholesterol-Induced Neutrophil Extracellular Trap Format… Co-author DOI 10.1158/0008-5472.can-25-2854↗
- DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2023.216288↗
- circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activation of MMPs in pancreatic cancer. Co-author DOI 10.1186/s12943-023-01847-2↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rui Kong · 4 shared papers, 2023–2026 · strength 0.75
- Paper Spatial Multiomics Analyses Reveal That Diabetes Promotes Pancreatic Cancer Progression by Stimulating Cholesterol-Indu… DOI 10.1158/0008-5472.can-25-2854↗
- Paper Tumour-infiltrating adipocyte-derived 12,13-DiHOME subverts CD8+ T cell immunity in pancreatic ductal adenocarcinoma by… DOI 10.1136/gutjnl-2025-337119↗
- Paper DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic canc… DOI 10.1016/j.canlet.2023.216288↗
- Guanqun Li · 3 shared papers, 2023–2026 · strength 0.60
- Paper Spatial Multiomics Analyses Reveal That Diabetes Promotes Pancreatic Cancer Progression by Stimulating Cholesterol-Indu… DOI 10.1158/0008-5472.can-25-2854↗
- Paper Tumour-infiltrating adipocyte-derived 12,13-DiHOME subverts CD8+ T cell immunity in pancreatic ductal adenocarcinoma by… DOI 10.1136/gutjnl-2025-337119↗
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Jisheng Hu · 3 shared papers, 2023–2026 · strength 0.60
- Paper Spatial Multiomics Analyses Reveal That Diabetes Promotes Pancreatic Cancer Progression by Stimulating Cholesterol-Indu… DOI 10.1158/0008-5472.can-25-2854↗
- Paper Tumour-infiltrating adipocyte-derived 12,13-DiHOME subverts CD8+ T cell immunity in pancreatic ductal adenocarcinoma by… DOI 10.1136/gutjnl-2025-337119↗
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Le Li · 2 shared papers, 2023–2026 · strength 0.39
- Paper Spatial Multiomics Analyses Reveal That Diabetes Promotes Pancreatic Cancer Progression by Stimulating Cholesterol-Indu… DOI 10.1158/0008-5472.can-25-2854↗
- Paper DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic canc… DOI 10.1016/j.canlet.2023.216288↗
- Yongwei Wang · 2 shared papers, 2023–2026 · strength 0.38
- Paper Spatial Multiomics Analyses Reveal That Diabetes Promotes Pancreatic Cancer Progression by Stimulating Cholesterol-Indu… DOI 10.1158/0008-5472.can-25-2854↗
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Bei Sun · 2 shared papers, 2023–2026 · strength 0.38
- Paper Spatial Multiomics Analyses Reveal That Diabetes Promotes Pancreatic Cancer Progression by Stimulating Cholesterol-Indu… DOI 10.1158/0008-5472.can-25-2854↗
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Xinglong Geng · 2 shared papers, 2023 · strength 0.30
- Paper DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic canc… DOI 10.1016/j.canlet.2023.216288↗
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Wenbo Yang · 2 shared papers, 2023 · strength 0.30
- Paper DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic canc… DOI 10.1016/j.canlet.2023.216288↗
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Zhongjie Zhao · 2 shared papers, 2023 · strength 0.30
- Paper DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic canc… DOI 10.1016/j.canlet.2023.216288↗
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Yangyang Zhang · 2 shared papers, 2023 · strength 0.30
- Paper DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic canc… DOI 10.1016/j.canlet.2023.216288↗
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Danxi Liu · 2 shared papers, 2023 · strength 0.30
- Paper DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic canc… DOI 10.1016/j.canlet.2023.216288↗
- Paper circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activati… DOI 10.1186/s12943-023-01847-2↗
- Gang Wang · 1 shared paper, 2026 · strength 0.24
- X W Bai · 1 shared paper, 2026 · strength 0.22
- Xinyuan Liu · 1 shared paper, 2026 · strength 0.22
- Yingmei Zhang · 1 shared paper, 2026 · strength 0.22
- Bo Sun · 1 shared paper, 2026 · strength 0.22
- Liwei Liu · 1 shared paper, 2023 · strength 0.15
- Hongze Chen · 1 shared paper, 2023 · strength 0.15
- Bei Sun · 1 shared paper, 2023 · strength 0.15
- Zengfu Song · 1 shared paper, 2023 · strength 0.14
- Chundong Cheng · 1 shared paper, 2023 · strength 0.14
- Shangha Pan · 1 shared paper, 2023 · strength 0.14
- Hongze Chen · 1 shared paper, 2023 · strength 0.14
- Le Li · 1 shared paper, 2023 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.